相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma
Graeme Eisenhofer et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?
Amanda J. Seabrook et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer
Daniel R. Crooks et al.
SCIENCE SIGNALING (2021)
Misleading 68GALLIUM-dotatate PET scan in a patient with a history of a phaeochromocytoma: Unsuspected uptake in papillary thyroid carcinoma metastases
Daniel Moffat et al.
JOURNAL OF NEUROENDOCRINOLOGY (2021)
Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression
Nathaniel Alzofon et al.
MOLECULAR CANCER RESEARCH (2021)
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
Laurence Amar et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion
Minghao Li et al.
DISCOVER ONCOLOGY (2021)
Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
Sanjana Ballal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBG
Matthew P. Thorpe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial
Edward Buitenwerf et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Risk of metastatic pheochromocytoma and paraganglioma in SDHx mutation carriers: a systematic review and updated meta-analysis
Hansong Lee et al.
JOURNAL OF MEDICAL GENETICS (2020)
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma
Dhaval Patel et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop
Patricia L. M. Dahia et al.
ENDOCRINE-RELATED CANCER (2020)
Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents
Ivana Jochmanova et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Screening guidelines and recommendations for patients at high risk of developing endocrine cancers
Jennifer L. Geurts et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
Xi-Feng Jin et al.
CANCERS (2020)
An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma
Alexandre Buffet et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
Jacques W. M. Lenders et al.
JOURNAL OF HYPERTENSION (2020)
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas
Paal W. Wallace et al.
JOURNAL OF PATHOLOGY (2020)
TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition
Aurelie Morin et al.
CELL REPORTS (2020)
Phase 2 study of pembrolizumab in patients with advanced rare cancers
Aung Naing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
History of the multiple endocrine neoplasia workshops and overview of MEN2019
Elizabeth Grubbs et al.
ENDOCRINE-RELATED CANCER (2020)
177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma
Sanjeet Kumar Jaiswal et al.
ENDOCRINE CONNECTIONS (2020)
Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma
Jingjing Jiang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma
Annika M. A. Berends et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas
Camilo Jimenez et al.
CANCERS (2020)
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas
Nicole Bechmann et al.
ENDOCRINE-RELATED CANCER (2020)
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Fassnacht et al.
ANNALS OF ONCOLOGY (2020)
Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis
Joakim Crona et al.
ENDOCRINE-RELATED CANCER (2019)
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
Segolene Hescot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma
Alexandre Buffet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Madhav Prasad Yadav et al.
EJNMMI RESEARCH (2019)
An analysis of surveillance screening for SDHB-related disease in childhood and adolescence
Nicola Tufton et al.
ENDOCRINE CONNECTIONS (2019)
The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the Literature
Adam Stenman et al.
CANCERS (2019)
Efficacy and Safety of Ablative Therapy in the Treatment of Patients with Metastatic Pheochromocytoma and Paraganglioma
Jacob Kohlenberg et al.
CANCERS (2019)
Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma
Abhishek Jha et al.
FRONTIERS IN ONCOLOGY (2019)
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
Grainne M. O'Kane et al.
BRITISH JOURNAL OF CANCER (2019)
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE
Wouter T. Zandee et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma
Radovan Bilek et al.
CANCERS (2019)
A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position
Jessica Boyd et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
David Taieb et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function
Will Bailis et al.
NATURE (2019)
A phase I clinical trial for [131I] meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Hiroshi Wakabayashi et al.
SCIENTIFIC REPORTS (2019)
y Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
Laura Gieldon et al.
CANCERS (2019)
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE
Achyut Ram Vyakaranam et al.
CANCERS (2019)
'Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta-analysis'
Swayamjeet Satapathy et al.
CLINICAL ENDOCRINOLOGY (2019)
Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups
David Taieb et al.
ENDOCRINE-RELATED CANCER (2019)
Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion
Aikaterini Geroula et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Diagnostic Accuracy of Computed Tomography to Exclude Pheochromocytoma: A Systematic Review, Meta-analysis, and Cost Analysis
Edward Buitenwerf et al.
MAYO CLINIC PROCEEDINGS (2019)
Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
Svenja Noelting et al.
CANCERS (2019)
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
Sylvie Job et al.
CLINICAL CANCER RESEARCH (2019)
Can subunit-specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?
Nicola Tufton et al.
CLINICAL ENDOCRINOLOGY (2019)
Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Daniel A. Pryma et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy
Shaunak Navalkissoor et al.
NEUROENDOCRINOLOGY (2019)
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas
Laura Remacha et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy
Hartmut P. H. Neumann et al.
JAMA NETWORK OPEN (2019)
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures
Maria Fankhauser et al.
ENDOCRINOLOGY (2019)
Bilateral biochemically silent pheochromocytoma, not silent after all
Robert Zakhia El-Doueihi et al.
UROLOGY CASE REPORTS (2019)
Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population
Abhishek Jha et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma
Richard B. Noto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Activating FGFR1 Mutations in Sporadic Pheochromocytomas
Jenny Welander et al.
WORLD JOURNAL OF SURGERY (2018)
A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: a case report
Ying Pang et al.
BMC CANCER (2018)
Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas
Alexandre Buffet et al.
CANCER RESEARCH (2018)
Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy
Irfan Jawed et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB-Mutated Cluster I Pheochromocytoma and Paraganglioma
Ying Pang et al.
CLINICAL CANCER RESEARCH (2018)
Role of DOTATATE-PET/CT in preoperative assessment of phaeochromocytoma and paragangliomas
Matti L. Gild et al.
CLINICAL ENDOCRINOLOGY (2018)
Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan
Mitsuhide Naruse et al.
ENDOCRINE JOURNAL (2018)
Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study
Edward Buitenwerf et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Gain-of-function mutations in DNMT3A in patients with paraganglioma
Laura Remacha et al.
GENETICS IN MEDICINE (2018)
18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma
David Taieb et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD
Katrina A. Andrews et al.
JOURNAL OF MEDICAL GENETICS (2018)
Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery
Pavel Nockel et al.
SURGERY (2018)
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites
Graeme Eisenhofer et al.
CLINICAL CHEMISTRY (2018)
Bayesian approach to determining penetrance of pathogenic SDH variants
Diana E. Benn et al.
JOURNAL OF MEDICAL GENETICS (2018)
Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine
Noriko Kimura et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma
Alejandro Roman-Gonzalez et al.
ANNALS OF SURGERY (2018)
Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature
Isabel Tena et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2018)
The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers
J. A. Rijken et al.
CLINICAL GENETICS (2018)
External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma
William Breen et al.
ADVANCES IN RADIATION ONCOLOGY (2018)
Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers
Nicola Tufton et al.
CLINICAL ENDOCRINOLOGY (2017)
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Joakim Crona et al.
ENDOCRINE REVIEWS (2017)
SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations
Ivana Jochmanova et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
Grace Kong et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years
Oksana Hamidi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes
Ingo Janssen et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
Konstantinos Nastos et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma
Yasmine Assadipour et al.
SURGERY (2017)
Mitochondrial Complex II: At the Crossroads
Ayenachew Bezawork-Geleta et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas
Shiko Asai et al.
HORMONES & CANCER (2017)
Review of Pediatric Pheochromocytoma and Paraganglioma
Reshma Bholah et al.
FRONTIERS IN PEDIATRICS (2017)
Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas
Laura Remacha et al.
CLINICAL CANCER RESEARCH (2017)
Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: A systematic review and meta-analysis
Oksana Hamidi et al.
CLINICAL ENDOCRINOLOGY (2017)
Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours
Alfred King-yin Lam
ENDOCRINE PATHOLOGY (2017)
Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma
Sina Jasim et al.
ENDOCRINE (2017)
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood
Surya P. Rednam et al.
CLINICAL CANCER RESEARCH (2017)
Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series
Veljko Strajina et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas
Rodrigo A. Toledo et al.
CLINICAL CANCER RESEARCH (2016)
Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases
Aurelien Archier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI
Ingo Janssen et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Pheochromocytoma: The First Metabolic Endocrine Cancer
Ivana Jochmanova et al.
CLINICAL CANCER RESEARCH (2016)
CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY
Hana Turkova et al.
ENDOCRINE PRACTICE (2016)
Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome
Roland Darr et al.
ENDOCRINE-RELATED CANCER (2016)
Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1
Lori Kepenekian et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations
Eleni Daniel et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma
P. F. Plouin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome
Sarah M. Nielsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao et al.
LANCET (2016)
Peptide receptor radionuclide therapy for metastatic paragangliomas
David J. Pinato et al.
MEDICAL ONCOLOGY (2016)
Head and Neck Paragangliomas: An Update on Evaluation and Management
Michael G. Moore et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2016)
Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma
Ingo Janssen et al.
CLINICAL CANCER RESEARCH (2015)
Peptide receptor radionuclide therapy with 90Y/177Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)
Ameya D. Puranik et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
Andrea Luchetti et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Lauren Fishbein et al.
NATURE COMMUNICATIONS (2015)
Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature
Timo Deutschbein et al.
CLINICAL ENDOCRINOLOGY (2015)
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
Judith Favier et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma
Dirk Weismann et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
The Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas
Ryan J. Ellis et al.
ANNALS OF SURGERY (2014)
The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study
Jan Schovanek et al.
BMC CANCER (2014)
Biochemical diagnosis of phaeochromocytoma using plasma- free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions
Roland Daerr et al.
CLINICAL ENDOCRINOLOGY (2014)
I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis
L. T. van Hulsteijn et al.
CLINICAL ENDOCRINOLOGY (2014)
Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis
N. D. Niemeijer et al.
CLINICAL ENDOCRINOLOGY (2014)
Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas
David Taieb et al.
ENDOCRINE REVIEWS (2014)
Long-term prognosis of patients with pediatric pheochromocytoma
Birke Bausch et al.
ENDOCRINE-RELATED CANCER (2014)
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
Noriko Kimura et al.
ENDOCRINE-RELATED CANCER (2014)
Combination of 13-Cis Retinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice
Svenja Noelting et al.
ENDOCRINOLOGY (2014)
Clinical utility of chromogranin A in SDHx-related paragangliomas
Samuel Zuber et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
Luis Jaime Castro-Vega et al.
HUMAN MOLECULAR GENETICS (2014)
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
Julien Hadoux et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X
Nan Qin et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Treatment of Head and Neck Paragangliomas With External Beam Radiation Therapy
Charles Dupin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
The Clinical Phenotype of SDHC-Associated Hereditary Paraganglioma Syndrome (PGL3)
Tobias Else et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma
Jenny Welander et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
Jacques W. M. Lenders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study
Frederic Castinetti et al.
LANCET ONCOLOGY (2014)
NEUROENDOCRINE CANCER Closing the GAPP on predicting metastases
Graeme Eisenhofer et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
External beam radiation therapy in treatment of malignant pheochromocytoma and paraganglioma
Jennifer Vogel et al.
FRONTIERS IN ONCOLOGY (2014)
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Eric Letouze et al.
CANCER CELL (2013)
Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma
Mariam Jafri et al.
CLINICAL ENDOCRINOLOGY (2013)
The management of head-and-neck paragangliomas
Cristina Capatina et al.
ENDOCRINE-RELATED CANCER (2013)
Surgical resection of multiple liver metastasis of functional malignant pheochromocytoma: A case report and literature review
Shaozhong Wei et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2013)
Bone Metastases and Skeletal-Related Events in Patients With Malignant Pheochromocytoma and Sympathetic Paraganglioma
Montserrat Ayala-Ramirez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
New Syndrome of Paraganglioma and Somatostatinoma Associated With Polycythemia
Karel Pacak et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Response after Surgical Resection of Metastatic Pheochromocytoma and Paraganglioma: Can Postoperative Biochemical Remission Be Predicted?
Ryan J. Ellis et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2013)
Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
Ivana Jochmanova et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
High-Throughput Screening for Growth Inhibitors Using a Yeast Model of Familial Paraganglioma
Irina Bancos et al.
PLOS ONE (2013)
Combination Chemotherapy with Cyclophosphamide, Vincristine, and Dacarbazine in Patients with Malignant Pheochromocytoma and Paraganglioma
Akiyo Tanabe et al.
HORMONES & CANCER (2013)
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas Insights from the largest single-institutional experience
Montserrat Ayala-Ramirez et al.
CANCER (2012)
Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas
Do-Youn Oh et al.
CANCER (2012)
MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Nelly Burnichon et al.
CLINICAL CANCER RESEARCH (2012)
Signaling Pathways in Pheochromocytomas and Paragangliomas: Prospects for Future Therapies
Svenja Noelting et al.
ENDOCRINE PATHOLOGY (2012)
False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease
Jay S. Fonte et al.
ENDOCRINE-RELATED CANCER (2012)
Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status
Graeme Eisenhofer et al.
EUROPEAN JOURNAL OF CANCER (2012)
Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Individuals with Neck or Mediastinal Paraganglioma (PGL)
S. Zovato et al.
HORMONE AND METABOLIC RESEARCH (2012)
An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes
A. -P. Gimenez-Roqueplo et al.
HORMONE AND METABOLIC RESEARCH (2012)
Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas
Montserrat Ayala-Ramirez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines
Svenja Noelting et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhengping Zhuang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
HIF1 alpha and HIF2 alpha: sibling rivalry in hypoxic tumour growth and progression
Brian Keith et al.
NATURE REVIEWS CANCER (2012)
Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of Pheochromocytoma
Graeme Eisenhofer et al.
CLINICAL CHEMISTRY (2011)
Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma
Graeme Eisenhofer et al.
ENDOCRINE-RELATED CANCER (2011)
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2011)
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Anna Imhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Adrenal Imaging
Michael A. Blake et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas
Li Yao et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
Yuejuan Qin et al.
NATURE GENETICS (2010)
Genotype-Phenotype Correlations in VHL Exon Deletions
Alisdair McNeill et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Clinical Utility of Temozolomide in the Treatment of Malignant Paraganglioma: A Preliminary Report
E. L. Bravo et al.
HORMONE AND METABOLIC RESEARCH (2009)
Novel and Evolving Therapies in the Treatment of Malignant Phaeochromocytoma: Experience with the mTOR Inhibitor Everolimus (RAD001)
M. R. Druce et al.
HORMONE AND METABOLIC RESEARCH (2009)
Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
Sara Gonias et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
Francien H. van Nederveen et al.
LANCET ONCOLOGY (2009)
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues
C. G. Ziegler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma
Graeme Eisenhofer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Treatment of Malignant Pheochromocytoma/Paraganglioma With Cyclophosphamide, Vincristine, and Dacarbazine Recommendation From a 22-Year Follow-up of 18 Patients
Hui Huang et al.
CANCER (2008)
Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers
Umasuthan Srirangalingam et al.
CLINICAL ENDOCRINOLOGY (2008)
The kinesin KIF1B beta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
Susanne Schlisio et al.
GENES & DEVELOPMENT (2008)
Biochemically Silent Abdominal Paragangliomas in Patients with Mutations in the Succinate Dehydrogenase Subunit B Gene
Henri J. L. M. Timmers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis
Vivian E. Strong et al.
SURGERY (2008)
Recent advances in the diagnosis and treatment of pheochromocytoma in children
Andrew D. Ludwig et al.
AMERICAN JOURNAL OF SURGERY (2007)
Approach to the patient - Preoperative management of the pheochromocytoma patient
Karel Pacak
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Adverse drug reactions in patients with phaeochromocytoma - Incidence, prevention and management
Graeme Eisenhofer et al.
DRUG SAFETY (2007)
Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours
Martijn Van Essen et al.
ACTA ONCOLOGICA (2007)
Posterior retroperitoneoscopic adrenalectomy - results of 560 procedures in 520 patients
Martin K. Walz et al.
SURGERY (2006)
Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines
G Eisenhofer et al.
CLINICAL CHEMISTRY (2005)
Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma
L Amar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour
K Pacak et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome
G Eisenhofer et al.
ENDOCRINE-RELATED CANCER (2004)
The management of benign and malignant pheochromocytoma and abdominal paraganglioma
EE Elder et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Angiogenesis and vascular architecture in pheochromocytomas - Distinctive traits in malignant tumors
J Favier et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms - A clinicopathologic and immunophenotypic study of 100 cases
LDR Thompson
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Biochemical diagnosis of pheochromocytoma - Which test is best?
JWM Lenders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
分享论文
